<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To assess the usefulness of an estimated <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (EPE) using the protein to <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (P/C ratio) in a random urine sample for follow-up evaluation of kidney function in diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>Research designs and methods: 410 newly registered Type 2 diabetic patients had annual follow-up for 6 years (M:F 263:147) </plain></SENT>
<SENT sid="2" pm="."><plain>EPE was calculated by estimation of P/C ratio in random urine sample </plain></SENT>
<SENT sid="3" pm="."><plain>Based on the EPE they were divided into those with <z:mpath ids='MPATH_458'>normal</z:mpath> protein excretion (&lt;100 mg/dl), mild <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (100 to &lt;500 mg/dl) and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (persistent <z:hpo ids='HP_0000093'>proteinuria</z:hpo> &gt;500mg/dl) cases </plain></SENT>
<SENT sid="4" pm="."><plain>The study subjects were divided into 4 groups based on the <z:hpo ids='HP_0000093'>proteinuria</z:hpo> status at follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>Anthropometry, measurement of blood pressure and <z:hpo ids='HP_0000488'>retinopathy</z:hpo> were carried out for <z:hpo ids='HP_0000001'>all</z:hpo> study subjects </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: at the baseline, 342 (83.4%) had <z:mpath ids='MPATH_458'>normal</z:mpath> protein excretion, 53 (12.9%) had mild <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and 15 (3.7%) had <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>At the follow-up the respective numbers were 276 (67.3%), 64 (15.6%) and 70(17%) </plain></SENT>
<SENT sid="8" pm="."><plain>During the study period <z:hpo ids='HP_0000112'>nephropathy</z:hpo> developed in 55 (13.4%) and mild <z:hpo ids='HP_0000093'>proteinuria</z:hpo> in 11 (2.7%) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000112'>Nephropathy</z:hpo> developed in 32 (6.7%) subjects in the non-<z:hpo ids='HP_0000093'>proteinuria</z:hpo> group and in 23 (43.4%) of the mild proteinuric subjects </plain></SENT>
<SENT sid="10" pm="."><plain>Conversion to <z:hpo ids='HP_0000112'>nephropathy</z:hpo> was greater in the latter group (chi(2)=41.6, P&lt;0.0001) </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000112'>Nephropathy</z:hpo> cases had higher duration of <z:mp ids='MP_0002055'>diabetes</z:mp> at the baseline (8.8+/-6.4 years) and at follow-up (7.1+/-6.0 years) and higher prevalence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> when compared with non-proteinuric group (60 and 43.5% compared with 11.1%, P&lt;0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>New cases of <z:hpo ids='HP_0000822'>hypertension</z:hpo> were detected in 32.8% of proteinuric and 0.7% of <z:mpath ids='MPATH_458'>normal</z:mpath> protein excretion subjects (chi(2)=32 </plain></SENT>
<SENT sid="13" pm="."><plain>24, P=0.0001) </plain></SENT>
<SENT sid="14" pm="."><plain>During the follow-up 55 of the 70 <z:hpo ids='HP_0000112'>nephropathy</z:hpo> subjects (78.6%) developed <z:hpo ids='HP_0000488'>retinopathy</z:hpo> compared with ten out of the 276 subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> protein excretion (3.6%) (chi(2)=200.6, P=0 </plain></SENT>
<SENT sid="15" pm="."><plain>0001) </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSION: EPE is useful in serial evaluation of kidney function </plain></SENT>
<SENT sid="17" pm="."><plain>The risk conferred by <z:hpo ids='HP_0000822'>hypertension</z:hpo>, mild <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and duration of <z:mp ids='MP_0002055'>diabetes</z:mp> in producing <z:hpo ids='HP_0000112'>nephropathy</z:hpo> are also highlighted </plain></SENT>
<SENT sid="18" pm="."><plain>EPE could be used in developing countries to assess the renal function on a follow-up basis </plain></SENT>
</text></document>